Blog - Litchlab

EN

CN

{$ImageUrl,alt}

Blog

Home>Blog

FBSH-EDC Hydrogel: An Innovative Material from Fetal Bovine Skin Tissue to Skin Repair

FBSH-EDC Hydrogel: An Innovative Material from Fetal Bovine Skin Tissue to Skin RepairIn the field of tissue engineering and regenerative medicine, naturally derived hydrogels have attracted significant attention due to their biocompatibility and soft structur...

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine Delivery

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine DeliveryLiposomes, as crucial carriers for vaccine delivery, possess unique structural and functional characteristics that enable them to meet the complex needs of various vaccines. Fr...

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development Driven by the COVID-19 pandemic, mRNA vaccines and lipid nanoparticle (LNP) delivery systems have become key technologies i...

HSA-PLGA Nanoparticles: Prescription Development and Optimization in CDMO Services

HSA-PLGA Nanoparticles: Prescription Development and Optimization in CDMO ServicesIn the field of pharmaceutical R&D, HSA-PLGA (human serum albumin–poly(lactic-co-glycolic acid)) nanoparticles have emerged as a novel platform for drug delivery and controll...

PAM/PANI Hydrogels: Ushering Drug Release into the Era of Smart Responsiveness

In the field of drug development, achieving precise and controlled drug release has long been a central challenge. Conventional delivery systems often suffer from limitations such as overly rapid or insufficiently slow release rates, making it difficult to mee...

DexMA Hydrogel as a Next-Generation Platform for Medical and Pharmaceutical Commercialization

Commercial Applications of DexMA Hydrogels in the Medical and Pharmaceutical FieldHydrogels are a class of biomaterials that have gained tremendous attention in biomedical science due to their high water content, biocompatibility, and tunable properties. Among...

Commercial Applications of HAMA hydrogel in the Medical and Pharmaceutical Field

Commercial Applications of HAMA hydrogel in the Medical and Pharmaceutical FieldIntroductionHyaluronic acid (HA) is a naturally occurring polysaccharide widely distributed in connective, epithelial, and neural tissues. Owing to its exceptional biocompatibility...

Commercial Applications of GeIMA in the Medical and Pharmaceutical Field

Commercial Applications of GeIMA in the Medical and Pharmaceutical FieldIntroductionThe intersection of biomaterials science and clinical medicine is one of the most dynamic areas of innovation in the 21st century. Among the many emerging candidates, GeIMA (ge...

Litchlab Launches SynerLipo™ Platform to Accelerate Co-Loaded Liposomal Oncology Therapeutics and Global CDMO Engagements

Litchlab, an innovation-focused contract development and manufacturing organization (CDMO) specializing in complex drug delivery systems, has officially launched its next-generation liposome platform — SynerLipo™. Engineered for dual-drug co-encapsulation, coo...

上一页 1 2 3 4 5 下一页